Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Revenue projections:

Revenue projections for LALPATHLAB
Revenue projections for LALPATHLAB

LALPATHLAB is projected to see lower revenues than in the previous year, a trend that usually concerns investors. Declining revenues often harm a company's profitability, leading investors to exercise caution as they weigh the potential risks of continued financial downturns.

Financial Ratios:

currentRatio 3.38800
forwardPE 40.48421
debtToEquity 7.13300
earningsGrowth 0.83100
revenueGrowth 0.10500
grossMargins 0.60839
operatingMargins 0.22005
trailingEps 58.40000
forwardEps 29.38000

LALPATHLAB's current ratio is 3.388, signaling that the company has sufficient cash reserves and current assets to cover its short-term debt obligations. This suggests financial stability, as LALPATHLAB should not face any issues meeting its short-term liabilities with available resources.
Dr. Lal PathLabs Limited's positive earnings and revenue growth indicate that the company is expected to continue expanding its business. These trends reflect strong financial health, with increasing profits and sales suggesting sustained growth and success for Dr. Lal PathLabs Limited.
LALPATHLAB's positive gross and operating margins highlight its profitability and operational efficiency. These strong margins demonstrate the company's ability to control costs while generating substantial revenue, contributing to a healthy financial performance.
LALPATHLAB's forward EPS being lower than its trailing EPS suggests that the company is expected to see a decline in profitability. This signals that the company may face a challenging financial year ahead.

Price projections:

Price projections for LALPATHLAB
Price projections for LALPATHLAB

Price projections for LALPATHLAB have been gradually reduced, reflecting growing uncertainty about the company's future performance. The downward revisions indicate analysts are lowering their expectations for LALPATHLAB's market trajectory.

Insider Transactions:

Insider Transactions for LALPATHLAB
Insider Transactions for LALPATHLAB


Dr. Lal PathLabs Limited saw 45 transactions in which shares were sold with market price at 3100.1844346788193.During the period under consideration, there were no sell transactions.The recent trend of more purchases than sales at Dr. Lal PathLabs Limited's current price could signal investor optimism. This pattern may point to a positive outlook for the stock, as it indicates growing confidence in its potential to perform well in the future.

Recommendation changes over time:

Recommendations trend for LALPATHLAB
Recommendations trend for LALPATHLAB


A recent buy bias from analysts toward LALPATHLAB may inspire confidence in investors, who could view the stock as a promising investment. This positive sentiment suggests that LALPATHLAB might be an appealing option for those looking to grow their wealth through stock market investments.